Mallinckrodt Unveils $1.6 Billion Opioid Deal — And Generic Stocks Pop
Shares of generic pharma companies popped Tuesday after Mallinckrodt announced a $1.6 billion opioid settlement and Perrigo gained Food and Drug Administration approval for an inhaler.